Gluebodies improve crystal reliability and diversity through transferable nanobody mutations that introduce constitutive close contacts
Mingda Ye,Mpho Makola,Joseph Newman,Michael Fairhead,Elizabeth MacLean,Nathan David Wright,Lizbe Koekemoer,Andrew Thompson,Gustavo Arruda Bezerra,Gangshun Yi,Huanyu Li,Victor Lopes Rangel,Dimitrios Mamalis,Hazel Aitkenhead,Benjamin G. Davis,Robert J.C. Gilbert,Katharina Duerr,Opher Gileadi,Frank von Delft
DOI: https://doi.org/10.1101/2022.07.26.501559
2024-06-13
Abstract:The design of proteins that may assemble in a manner that is transferable and modular remains an enduring challenge. In particular, obtaining well-diffracting protein crystals suitable for characterizing ligands or drug candidates and understanding different protein conformations remains a bottleneck for structural studies. Using nanobodies as crystallization chaperones is one strategy to address the problem, but its reliability is uncharacterized and, in this study, we observed it to have a limited success rate. Here we show that by exploring and testing the nanobody-nanobody interfaces predominant in >200 combinations of surface mutations in multiple iterations we can engineer robust crystallization behaviour into the nanobody scaffold. Strikingly, this survey yielded multiple polymorphs, all mediated by the same interface. The resulting 'Gluebodies' (Gbs) provide far superior resolution and reliability of diffraction and can be routinely generated for chaperone experiments. We furthermore show that Gbs cannot rescue intrinsically non-crystallizing proteins, but instead are a powerful approach to improve the packing and resolution limit of poorly diffracting crystals. The discovery of an engineered, preferred nanobody interface that arises under kinetic control - trapped here by irreversible crystallization - embodies a protein assembly strategy that could prove even more broadly useful for modular assembly trapped by other irreversible methods.
Biochemistry